ArticleThyroid : official journal of the American Thyroid Association2013

The PLK1 inhibitor GSK461364A is effective in poorly differentiated and anaplastic thyroid carcinoma cells, independent of the nature of their driver mutations.

Marika A Russo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.